{"nctId":"NCT03927781","briefTitle":"Perioperative Pregabalin in Ureteroscopy: a Pilot","startDateStruct":{"date":"2019-04-01","type":"ACTUAL"},"conditions":["Nephrolithiasis","Urolithiasis","Perioperative/Postoperative Complications","Pain, Postoperative","Pain, Acute","Anesthesia","Urologic Diseases","Anesthesia Morbidity"],"count":10,"armGroups":[{"label":"Pregabalin 300mg","type":"EXPERIMENTAL","interventionNames":["Drug: Pregabalin 300mg"]}],"interventions":[{"name":"Pregabalin 300mg","otherNames":["Lyrica","Gabapentinoid"]}],"eligibilityModule":{"eligibilityCriteria":"Subject Population Undergoing elective ureteroscopy with stent placement by Dr. Murray at University of Missouri Hospital and affiliated facilities\n\nSubject Inclusion\n\nAge \\>= 18 years\n\nSubject Exclusion\n\n* Renal insufficiency (eGFR \\< 30 mL/minute/1.73 m2)\n* Chronic indwelling ureteral stent\n* Chronic opioid use\n* History of opioid abuse\n* Chronic gabapentinoid use\n* Plan for inpatient hospitalization\n* Pregnancy\n* Inability of the patient to consent for themselves in English\n* Allergy to gabapentinoid\n* Liver failure or hepatic dysfunction","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With One or More Adverse Events Related to Study Drug","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants Who Were Administered the Study Drug Correctly","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null}]}]}]},{"type":"PRIMARY","title":"Respondent Reported Usability of Instruments","description":"Number of patients able to complete 30 day post op questionnaire","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Early Post-op Stent Related Symptoms","description":"Ureteral Stent Related Symptom Questionnaire (USSQ) score, sum of urinary index score, pain index score, and general health index score. Minimum is 24. Maximum is 162. Higher scores indicate a worse outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null}]}]}]},{"type":"SECONDARY","title":"Early Post-op Opioid Needs","description":"Number of patients with a verified prescription for narcotic medication within the first 30 post-operative days.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Opioid Use","description":"Number of patients stating that they had used opioids on any survey.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Amount of Opioid Use","description":"Total amount of opioid used for any indication at several time points, in oral morphine equivalents. This is the sum for all patients.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]}]},{"type":"SECONDARY","title":"Unplanned Healthcare Contacts","description":"Number of unplanned contacts between the patient and the healthcare system. This is the total for all patients.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Patient Satisfaction","description":"Score on standardized evaluation of patient satisfaction at 7-days post-op. This was on a scale from 1) very dissatisfied to 5) very satisfied. Higher scores are better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Dry mouth","Pain","Increased appetite","Back pain","Fatigue"]}}}